# To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

> **NCT01162538** · — · UNKNOWN · sponsor: **Centre Hospitalier Intercommunal Robert Ballanger** · enrollment: 60 (estimated)

## Conditions studied

- Evaluated
- Non B Subtype
- Naive Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01162538
- **Lead sponsor:** Centre Hospitalier Intercommunal Robert Ballanger
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2012-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01162538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01162538, "To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01162538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*